Skip to main content
. 2005 Sep 9;5:e10. doi: 10.5334/ijic.135

Table 2.

Summary of clinical data in relation to MCN protocols

Area MCN Protocol Result
Difference between pre and post MCN p-value*
Pre MCN (n=97) Post MCN (n=105)
Immediate aspirin All to receive immediate aspirin 63.6% 67.7% 0.56
Thrombolysis All to be considered for thrombolysis 48.3% 59% 0.14
50% to achieve door to needle target (≤30 minutes) 31% 45.6% 0.14
Achieve pain to needle target (≤90 minutes) 15% 32.7% 0.05
Median pain to needle times (hh:mm [range]) 2:27 [10:45] 2:09 [10:17] 0.2°
Discharge medication 70% on antiplatelet agents 97.6% 97.9% 0.89
70% on betablockade 60.2% 68.1% 0.28
70% on ACEI 90.2% 88.4% 0.70
70% on Statin (with cholesterol >5.00) 78.6% 88.7% 0.10
Cardiac rehabilitation All seen by rehab nurse pre discharge 96.4% 96.8% 0.87
All have out-patient rehab arranged pre discharge 88.8% 92.4% 0.41
All attend out-patient rehab programme 75.9% 76.4% 0.94
Secondary prevention at 6 months post MI 70% on antiplatelet agents 98.8% 97.8% 0.62
70% on betablockade 61.3% 75% 0.05
70% on ACEI 87.3% 85.4% 0.71
70% on Statin (with cholesterol >5.00) 80.3% 95.5% 0.007
*

Refers to chi-squared test of difference for pre-post comparisons.

°: Refers to Mann-Whitney test of difference for pre-post comparisons.